BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 2525772)

  • 1. [Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency].
    Drüeke T; Zins B; Bererhi L; Casadevall N; Varet B
    Presse Med; 1989 Jun; 18(25):1235-7. PubMed ID: 2525772
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of the anaemia of chronic renal failure with recombinant erythropoietin.
    Adamson JW; Eschbach JW
    Q J Med; 1989 Dec; 73(272):1093-101. PubMed ID: 2694210
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in therapy of renal anemia: darbepoetin alfa].
    Schaefer R
    Wien Klin Wochenschr; 2002 Dec; 114(23-24):955-7. PubMed ID: 12635460
    [No Abstract]   [Full Text] [Related]  

  • 5. Early intervention with recombinant human erythropoietin therapy.
    Teehan BP; Benz RL; Sigler MH; Brown JM
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):28-34. PubMed ID: 2192414
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant human erythropoietin in predialysis patients.
    Lim VS
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):34-7. PubMed ID: 1928077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 8. Sub-optimal doses of human recombinant erythropoietin markedly lower serum ferritin.
    Jones-Lecointe A; Green PJ; Lee HA
    Clin Lab Haematol; 1991; 13(3):251-3. PubMed ID: 1794227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
    Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
    Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of withdrawing erythropoietin.
    Taylor JE; Henderson IS; Mactier RA; Stewart WK
    BMJ; 1991 Feb; 302(6771):272-3. PubMed ID: 1998794
    [No Abstract]   [Full Text] [Related]  

  • 12. [Erythropoietin, blood viscosity and hypertension in chronic kidney failure].
    Schaefer RM; Heidland A
    Dtsch Med Wochenschr; 1989 Jun; 114(26):1046-9. PubMed ID: 2661190
    [No Abstract]   [Full Text] [Related]  

  • 13. Anemia: What can we learn from a secondary analysis of CHOIR?
    Hörl WH
    Nat Rev Nephrol; 2010 May; 6(5):251-2. PubMed ID: 20424625
    [No Abstract]   [Full Text] [Related]  

  • 14. Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency?
    Lim VS
    Semin Nephrol; 1990 Mar; 10(2 Suppl 1):26-7. PubMed ID: 2356366
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of the anemia of chronic renal failure with recombinant human erythropoietin.
    Adamson JW; Eschbach JW
    Annu Rev Med; 1990; 41():349-60. PubMed ID: 2184735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of erythropoietin in the treatment of the anemia due to chronic renal failure.
    Drüeke T; Zins B; Naret C; Casadevall N; Goureau Y; Bererhi L; Peterlongo F; Castaigne JP; Zingraff J; Delons S
    Adv Nephrol Necker Hosp; 1989; 18():187-206. PubMed ID: 2493715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of renal anemia with erythropoietin].
    Spustova V; Kovac A
    Bratisl Lek Listy; 1999 Aug; 100(8):432-8. PubMed ID: 10645031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. The Canadian Erythropoietin Study Group.
    Keown PA
    Contrib Nephrol; 1991; 88():81-6; discussion 87-9. PubMed ID: 2040199
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of renal anemia with recombinant human erythropoietin].
    Schaefer RM; Kürner B; Zech M; Krahn R; Heidland A
    Dtsch Med Wochenschr; 1988 Jan; 113(4):125-9. PubMed ID: 3276487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Review of the scientific evidence of the efficiency of erythropoietin use].
    García-Altés A; Puig-Junoy J
    Med Clin (Barc); 2006 Sep; 127(11):415-20. PubMed ID: 17020686
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.